the effect of lavender on anxiety and cognitio

Phase 3

Recruiting

• Conditions: Bipolar disorder.; Bipolar disorder

• Registration Number: IRCT20220915055965N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Admitted to the psychiatric department, all patients with ECT indication based on DSM-5 criteria with the diagnosis of a psychiatrist, consent to participate in the study, the ability to verbally communicate with the researchers, aged 25 to 55 years, patients benefit from minimal reading and writing literacy. (Middle or 8th grade), do not have any disease or physical disability such as speech, hearing or vision impairment, a positive smell test (olfactory nerve health test) is taken from them in such a way that the coffee sample is taken under their nose with their eyes closed and smell it), have no history of physical problems that lead to cognitive disorders such as mental retardation, epilepsy, dementia, and head trauma, no physical diseases related to anxiety and cognitive disorders such as pheochromocytoma, thyroid problems, and brain tumors, no bad Consuming alcohol and drugs, not taking anti-anxiety drugs, being aware of the time and place before the electroshock, having the physical and mental ability to answer questions, not having a history of allergies and respiratory diseases, schizophrenic patients who are dominated by negative symptoms and their reality check is impaired. are not eligible to enter the study.

Exclusion Criteria

Patients who have difficulty communicating verbally, withdraw from the study, have an allergy to lavender during the intervention, decrease the level of consciousness of the patient during the study, participate in other studies that affect their anxiety and cognitive status.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety before and after the intervention. Timepoint: One hour before and one hour after electroconvulsive therapy. Method of measurement: Based on the average scores obtained from Beck Anxiety inventory and Montreal Cognitive Assessment (MOCA).;Cognitive status before and after the intervention. Timepoint: One hour before and one hour after electroconvulsive therapy. Method of measurement: Beck Anxiety Questionnaire and Montreal Cognitive Assessment (MOCA).